RxDoctor Payments Data

Todd Christiansen, MD

Psychiatry · Greenbelt, MDNPI 1174542963

Payments from drug & device makers

$274in general payments, 2019–2025

Across 15 payments — averaging $18.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$71
  • Johnson & Johnson$39
  • AbbVie$32
  • MDD US Operations, LLC$31
  • Supernus Pharmaceuticals, Inc.$30
  • Alkermes, Inc.$23
  • plus $48 from 3 others

What the payments were for

  • Food & beverage$27199%
  • Education$31%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$274 in reported general payments places this provider in the 60th percentile of 851 psychiatry providers in Maryland.

See all psychiatry providers in Maryland

Medicare billing

Part B allowed, 2024
$51,705
Medicare patients
78
Services billed
382

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl20$30,462
Invega SustennaPaliperidone Palmitate11$19,819
TrintellixVortioxetine Hydrobromide14$6,360
SuboxoneBuprenorphine Hcl/Naloxone Hcl11$6,139
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl43$4,513
Lurasidone Hcl12$1,878
Bupropion XlBupropion Hcl49$1,875
Aripiprazole26$1,862
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine38$1,507
Paroxetine ErParoxetine Hcl11$1,340
Fluphenazine Hcl12$1,209
Quetiapine Fumarate77$1,188
Trazodone Hcl91$1,092
Olanzapine43$1,088
Venlafaxine Hcl ErVenlafaxine Hcl32$877

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$32$30,46220 claims
Johnson & JohnsonInvega Sustenna$39$19,81911 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$16$6,36014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 851 psychiatry providers in Maryland.

Other psychiatry in Greenbelt

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →